CNSY ▼ -1.7% - Cerenome, Inc.
$CNSY - Cerenome Completes Enrollment in Phase 2 ReSPECT-GBM Trial of REYOBIQ™ in Recurrent Glioblastoma
29-OCT-2026 07:30 AM ET
Share this post
More filings for $CNSY
CNSY ▲ +1.9% - Cerenome, Inc.Oct 6, 2026CNSY ▲ +7.5% - Cerenome, Inc.Sep 30, 2026CNSY ▼ -1.6% - Cerenome, Inc.Sep 25, 2026CNSY ▲ +3.2% - Cerenome, Inc.Sep 22, 2026CNSY ▼ -2.8% - Cerenome, Inc.Sep 16, 2026CNSY ▲ +1.2% - Cerenome, Inc.Sep 10, 2026
View full $CNSY filing history →💬 Comments
Loading comments…
Leave a comment